AAAAAA
Results:
1-13
|
Results: 13
Authors:
Talley, NJ
Verlinden, M
Jones, M
Citation: Nj. Talley et al., Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form, ALIM PHARM, 15(2), 2001, pp. 207-216
Authors:
Christensen, CM
Raynor, M
Verlinden, M
Citation: Cm. Christensen et al., Skate to where the money will be, HARV BUS RE, 79(10), 2001, pp. 72
Authors:
Talley, NJ
Verlinden, M
Geenen, DJ
Hogan, RB
Riff, D
McCallum, RW
Mack, RJ
Citation: Nj. Talley et al., Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial, GUT, 49(3), 2001, pp. 395-401
Authors:
Talley, NJ
Verlinden, M
Jones, M
Citation: Nj. Talley et al., Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?, AM J GASTRO, 96(5), 2001, pp. 1422-1428
Authors:
van Zanten, SJOV
Jones, MJ
Verlinden, M
Talley, NJ
Citation: Sjov. Van Zanten et al., Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: A meta-analysis, AM J GASTRO, 96(3), 2001, pp. 689-696
Authors:
Van Herwaarden, MA
Samsom, M
Van Nispen, CHM
Verlinden, M
Smout, AJPM
Citation: Ma. Van Herwaarden et al., The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients, ALIM PHARM, 14(4), 2000, pp. 453-462
Authors:
Talley, NJ
Verlinden, M
Snape, W
Beker, JA
Ducrotte, P
Dettmer, A
Brinkhoff, H
Eaker, E
Ohning, G
Miner, PB
Mathias, JR
Fumagalli, I
Staessen, D
Mack, RJ
Citation: Nj. Talley et al., Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms offunctional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial, ALIM PHARM, 14(12), 2000, pp. 1653-1661
Authors:
Zinzen, E
Caboor, D
Verlinden, M
Cattrysse, E
Duquet, W
Van Roy, P
Clarys, JP
Citation: E. Zinzen et al., Will the use of dfferent prevalence rates influence the development of a primary prevention programme for low-back problems?, ERGONOMICS, 43(10), 2000, pp. 1789-1803
Authors:
Lee, JS
Camilleri, M
Zinsmeister, AR
Burton, DD
Choi, MG
Nair, KS
Verlinden, M
Citation: Js. Lee et al., Toward office-based measurement of gastric emptying in symptomatic diabetics using [C-13]octanoic acid breath test, AM J GASTRO, 95(10), 2000, pp. 2751-2761
Authors:
Clark, MJ
Wright, T
Bertrand, PP
Bornstein, JC
Jenkinson, KM
Verlinden, M
Furness, JB
Citation: Mj. Clark et al., Erythromycin derivatives ABT 229 and GM 611 act on motilin receptors in the rabbit duodenum, CLIN EXP PH, 26(3), 1999, pp. 242-245
Authors:
Furness, JB
Clark, MJ
Wright, T
Bertrand, PP
Bornstein, JC
Verlinden, M
Citation: Jb. Furness et al., An action of erythromycin in the intestine that is not mediated via motilin receptors, CLIN EXP PH, 26(2), 1999, pp. 100-104
Authors:
Talley, NI
Haque, M
Wyeth, JW
Stace, NH
Tytgat, GNJ
Stanghellini, V
Holtmann, G
Verlinden, M
Jones, M
Citation: Ni. Talley et al., Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index, ALIM PHARM, 13(2), 1999, pp. 225-235
Authors:
Talley, NJ
Verlinden, M
Jones, M
Citation: Nj. Talley et al., Validity of a new quality of life scale for functional dyspepsia: a UnitedStates multicenter trial of the Nepean Dyspepsia Index, AM J GASTRO, 94(9), 1999, pp. 2390-2397
Risultati:
1-13
|